on April 23, 2007
Published online before print April 23, 2007, doi: 10.1161/CIRCULATIONAHA.107.686576
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 7, 2007
From the Department of Physical Therapy (R.A.) and Department of Internal Medicine (M.A.P.), Virginia Commonwealth University, Health Sciences Campus, Richmond, Va; VA Palo Alto Health Care System (J.M., J.A.), Cardiology Division, Stanford University, Palo Alto, Calif; LeBauer Cardiovascular Research Foundation (D.B., P.C.), Greensboro, NC; and University of Milano (M.G.), San Paolo Hospital, Cardiopulmonary Laboratory, Cardiology Division, University of Milano, San Paolo Hospital, Milano, Italy. * To whom correspondence should be addressed. E-mail: raarena{at}.vcu.edu.
Background--Ventilatory efficiency, commonly assessed by the minute ventilation (VE)-carbon dioxide production (VCO2) slope, is a powerful prognostic marker in the heart failure population. The purpose of the present study is to refine the prognostic power of the VE/VCO2 slope by developing a ventilatory class system that correlates VE/VCO2 cut points to cardiac-related events. Methods and Results--Four hundred forty-eight subjects diagnosed with heart failure were included in this analysis. The VE/VCO2 slope was determined via cardiopulmonary exercise testing. Subjects were tracked for major cardiac events (mortality, transplantation, or left ventricular assist device implantation) for 2 years after cardiopulmonary exercise testing. There were 81 cardiac-related events (64 deaths, 10 heart transplants, and 7 left ventricular assist device implantations) during the 2-year tracking period. Receiver operating characteristic curve analysis revealed the overall VE/VCO2 slope classification scheme was significant (area under the curve: 0.78 [95% CI, 0.73 to 0.83], P<0.001). On the basis of test sensitivity and specificity, the following ventilatory class system was developed: (1) ventilatory class (VC) I: Conclusions--A multiple-level classificatory system based on exercise VE/VCO2 slope stratifies the burden of risk for the entire spectrum of heart failure severity. Application of this classification is therefore proposed to improve clinical decision making in heart failure.
Accepted on February 16, 2007
Development of a Ventilatory Classification System in Patients With Heart Failure
Ross Arena PhD, PT*,
29; (2) VC II: 30.0 to 35.9; (3) VC III: 36.0 to 44.9; and (4) VC IV: 
45.0. The numbers of subjects in VCs I through IV were 144, 149, 112, and 43, respectively. Kaplan-Meier analysis revealed event-free survival for subjects in VC I, II, III, and IV was 97.2%, 85.2%, 72.3%, and 44.2%, respectively (log-rank 86.8; P<0.001).
Key words: prognosis • ventilation • heart failure • exercise
This article has been cited by other articles:
 |
|
 |
|
  G. Caminiti, M. Volterrani, F. Iellamo, G. Marazzi, R. Massaro, M. Miceli, C. Mammi, M. Piepoli, M. Fini, and G. M.C. Rosano Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J. Am. Coll. Cardiol., September 1, 2009; 54(10): 919 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Glaser, C. Schaper, R. Ewert, and B. Koch Peak oxygen uptake and exercise capacity: a reliable predictor of quality of life? Eur. Heart J., July 1, 2009; 30(13): 1674 - 1674. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Magri, M. Brioschi, C. Banfi, J. P. Schmid, P. Palermo, M. Contini, A. Apostolo, M. Bussotti, E. Tremoli, S. Sciomer, et al. Circulating Plasma Surfactant Protein Type B as Biological Marker of Alveolar-Capillary Barrier Damage in Chronic Heart Failure Circ Heart Fail, May 1, 2009; 2(3): 175 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Corra, A. Mezzani, A. Giordano, E. Bosimini, and P. Giannuzzi Exercise haemodynamic variables rather than ventilatory efficiency indexes contribute to risk assessment in chronic heart failure patients treated with carvedilol Eur. Heart J., April 30, 2009; (2009) ehp138v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Lewis The role of the pulmonary vasculature in heart failure with preserved ejection fraction. J. Am. Coll. Cardiol., March 31, 2009; 53(13): 1127 - 1129. [Full Text] [PDF]
|
|
|
|
|
|
R. Arena, J. Myers, J. Abella, S. Pinkstaff, P. Brubaker, B. Moore, D. Kitzman, M. A. Peberdy, D. Bensimhon, P. Chase, et al. Determining the Preferred Percent-Predicted Equation for Peak Oxygen Consumption in Patients With Heart Failure Circ Heart Fail, March 1, 2009; 2(2): 113 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Lang, P. Karlin, J. Haythe, T. K. Lim, and D. M. Mancini Peak Cardiac Power Output, Measured Noninvasively, Is a Powerful Predictor of Outcome in Chronic Heart Failure Circ Heart Fail, January 1, 2009; 2(1): 33 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Guazzi, J. Myers, M. A. Peberdy, D. Bensimhon, P. Chase, and R. Arena Exercise oscillatory breathing in diastolic heart failure: prevalence and prognostic insights Eur. Heart J., November 2, 2008; 29(22): 2751 - 2759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Lewis, R. V. Shah, P. P. Pappagianopolas, D. M. Systrom, and M. J. Semigran Determinants of Ventilatory Efficiency in Heart Failure: The Role of Right Ventricular Performance and Pulmonary Vascular Tone Circ Heart Fail, November 1, 2008; 1(4): 227 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Guazzi Clinical Use of Phosphodiesterase-5 Inhibitors in Chronic Heart Failure Circ Heart Fail, November 1, 2008; 1(4): 272 - 280. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Arena, J. Myers, and M. Guazzi The Clinical Significance of Aerobic Exercise Testing and Prescription: From Apparently Healthy to Confirmed Cardiovascular Disease American Journal of Lifestyle Medicine, November 1, 2008; 2(6): 519 - 536. [Abstract] [PDF]
|
|
|
|
|
|
P. Agostoni, M. Emdin, U. Corra, F. Veglia, D. Magri, C. C. Tedesco, E. Berton, C. Passino, E. Bertella, F. Re, et al. Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients Eur. Heart J., October 1, 2008; 29(19): 2367 - 2372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Meadows, P. Lang, G. Marx, and J. Rhodes Fontan Fenestration Closure Has No Acute Effect on Exercise Capacity but Improves Ventilatory Response to Exercise J. Am. Coll. Cardiol., July 8, 2008; 52(2): 108 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Borghi-Silva, C. Carrascosa, C. C. Oliveira, A. C. Barroco, D. C. Berton, D. Vilaca, E. B. Lira-Filho, D. Ribeiro, L. E. Nery, and J. A. Neder Effects of respiratory muscle unloading on leg muscle oxygenation and blood volume during high-intensity exercise in chronic heart failure Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2465 - H2472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ingle Prognostic value and diagnostic potential of cardiopulmonary exercise testing in patients with chronic heart failure Eur J Heart Fail, February 1, 2008; 10(2): 112 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Guazzi, M. Samaja, R. Arena, M. Vicenzi, and M. D. Guazzi Long-Term Use of Sildenafil in the Therapeutic Management of Heart Failure J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2136 - 2144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Can Ventilatory Efficiency Be Used to Classify Patients with Heart Failure? Journal Watch Cardiology, June 6, 2007; 2007(606): 3 - 3. [Full Text]
|
|
|
|
 |
|
 D. Mancini and T. H. LeJemtel Is Ventilatory Classification Preferable to Peak Oxygen Consumption for Risk Stratification in Heart Failure? Circulation, May 8, 2007; 115(18): 2376 - 2378. [Full Text] [PDF]
|
|